Skip to main content
Equibles

UBS Group AG

Position in APLM — Apollomics Inc.

CIK 1610520 ZURICH, V8
Back to APLM Full portfolio

Position in APLM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$41
-$2,209 QoQ
Shares Held
2
-98.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 4 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APLM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,681,375 across 562 Biotechnology names. APLM ranks #539 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in APLM

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41 2
2026-03-31 $2,250 142
2025-12-31 $1,196 64
2025-09-30 — 16
2025-06-30 $47,761 7,283
2025-03-31 $14,551 2,347
2024-12-31 $1,686 173
2024-09-30 $18,678 131,539
2024-03-31 $5,634 7,512
2023-12-31 $31,011 32,136
2023-03-31 $10,018 414